Dr Stephen Thompson is a founding partner of Brandon Capital Partners. Prior to that, he was a director of Apax Partners based in London. Previously, he fulfilled roles in product development with UK biotechnology company Cantab Pharmaceuticals. Dr Thompson also spent 10 years as a research immunologist in London and California. He has an Honours degree in Immunology and Biochemistry, a PhD in Immunology from Kings College London, and an MBA from Imperial College London. Dr Thompson is a director of MecRx, Vaxxas, a former director of Elastagen which acquired by Allergan, and director of the Australian Venture Capital Association. He is a graduate of the Australian Institute of Company Directors.
Stephen Thompson
Non-Executive Chair / OncoRes Medical
Most Notable Role